149 related articles for article (PubMed ID: 9756772)
1. Development of a new cartridge radioimmunoassay for determination of intracellular levels of lamivudine triphosphate in the peripheral blood mononuclear cells of human immunodeficiency virus-infected patients.
Robbins BL; Tran TT; Pinkerton FH; Akeb F; Guedj R; Grassi J; Lancaster D; Fridland A
Antimicrob Agents Chemother; 1998 Oct; 42(10):2656-60. PubMed ID: 9756772
[TBL] [Abstract][Full Text] [Related]
2. Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy.
Moore JD; Acosta EP; Johnson VA; Bassett R; Eron JJ; Fischl MA; Long MC; Kuritzkes DR; Sommadossi JP
Antivir Ther; 2007; 12(6):981-6. PubMed ID: 17926654
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous quantitation of intracellular zidovudine and lamivudine triphosphates in human immunodeficiency virus-infected individuals.
Rodriguez JF; Rodriguez JL; Santana J; García H; Rosario O
Antimicrob Agents Chemother; 2000 Nov; 44(11):3097-100. PubMed ID: 11036029
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic Modeling of Lamivudine and Zidovudine Triphosphates Predicts Differential Pharmacokinetics in Seminal Mononuclear Cells and Peripheral Blood Mononuclear Cells.
Dumond JB; Yang KH; Kendrick R; Reddy YS; Kashuba AD; Troiani L; Bridges AS; Fiscus SA; Forrest A; Cohen MS
Antimicrob Agents Chemother; 2015 Oct; 59(10):6395-401. PubMed ID: 26239974
[TBL] [Abstract][Full Text] [Related]
5. Effect of HIV-1 infection and sex on the cellular pharmacology of the antiretroviral drugs zidovudine and lamivudine.
Rower JE; Meditz A; Gardner EM; Lichtenstein K; Predhomme J; Bushman LR; Klein B; Zheng JH; Mawhinney S; Anderson PL
Antimicrob Agents Chemother; 2012 Jun; 56(6):3011-9. PubMed ID: 22391541
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous quantitation of the 5'-triphosphate metabolites of zidovudine, lamivudine, and stavudine in peripheral mononuclear blood cells of HIV infected patients by high-performance liquid chromatography tandem mass spectrometry.
Moore JD; Valette G; Darque A; Zhou XJ; Sommadossi JP
J Am Soc Mass Spectrom; 2000 Dec; 11(12):1134-43. PubMed ID: 11118121
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study Team.
Sáez-Llorens X; Nelson RP; Emmanuel P; Wiznia A; Mitchell C; Church JA; Sleasman J; Van Dyke R; Richardson CG; Cutrell A; Spreen W; Hetherington S
Pediatrics; 2001 Jan; 107(1):E4. PubMed ID: 11134468
[TBL] [Abstract][Full Text] [Related]
8. High levels of zidovudine (AZT) and its intracellular phosphate metabolites in AZT- and AZT-lamivudine-treated newborns of human immunodeficiency virus-infected mothers.
Durand-Gasselin L; Pruvost A; Dehée A; Vaudre G; Tabone MD; Grassi J; Leverger G; Garbarg-Chenon A; Bénech H; Dollfus C
Antimicrob Agents Chemother; 2008 Jul; 52(7):2555-63. PubMed ID: 18426897
[TBL] [Abstract][Full Text] [Related]
9. Intracellular pharmacokinetics of once versus twice daily zidovudine and lamivudine in adolescents.
Flynn PM; Rodman J; Lindsey JC; Robbins B; Capparelli E; Knapp KM; Rodriguez JF; McNamara J; Serchuck L; Heckman B; Martinez J;
Antimicrob Agents Chemother; 2007 Oct; 51(10):3516-22. PubMed ID: 17664328
[TBL] [Abstract][Full Text] [Related]
10. Concentrations of zidovudine- and lamivudine-triphosphate according to cell type in HIV-seronegative adults.
Anderson PL; Zheng JH; King T; Bushman LR; Predhomme J; Meditz A; Gerber J; Fletcher CV
AIDS; 2007 Sep; 21(14):1849-54. PubMed ID: 17721092
[TBL] [Abstract][Full Text] [Related]
11. Differential extracellular and intracellular concentrations of zidovudine and lamivudine in semen and plasma of HIV-1-infected men.
Dumond JB; Reddy YS; Troiani L; Rodriguez JF; Bridges AS; Fiscus SA; Yuen GJ; Cohen MS; Kashuba AD
J Acquir Immune Defic Syndr; 2008 Jun; 48(2):156-62. PubMed ID: 18360288
[TBL] [Abstract][Full Text] [Related]
12. Single-dose pharmacokinetics and safety of abacavir (1592U89), zidovudine, and lamivudine administered alone and in combination in adults with human immunodeficiency virus infection.
Wang LH; Chittick GE; McDowell JA
Antimicrob Agents Chemother; 1999 Jul; 43(7):1708-15. PubMed ID: 10390227
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the steady-state pharmacokinetics and safety of abacavir, lamivudine, and zidovudine taken as a triple combination tablet and as abacavir plus a lamivudine-zidovudine double combination tablet by HIV-1-infected adults.
Crémieux AC; Katlama C; Gillotin C; Demarles D; Yuen GJ; Raffi F;
Pharmacotherapy; 2001 Apr; 21(4):424-30. PubMed ID: 11310515
[TBL] [Abstract][Full Text] [Related]
14. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
[TBL] [Abstract][Full Text] [Related]
15. The effect of hydroxyurea on the phosphorylation of zidovudine and lamivudine in human umbilical vein endothelial cells.
McGuire TR; Hoie EB; Manouilov KK; Gwilt PG
In Vitro Cell Dev Biol Anim; 2003; 39(7):280-2. PubMed ID: 14572303
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of triple combination therapy with zidovudine (ZDV) plus zalcitabine (ddC) plus lamivudine (3TC) versus double (ZDV+3TC) combination therapy in patients previously treated with ZDV+ddC.
Ruiz L; Romeu J; Martínez-Picado J; Schmit JC; Vandamme AM; Balagué M; Cabrera C; Puig T; Tural C; Segura A; Sirera G; De Clercq E; Clotet B
AIDS; 1996 Dec; 10(14):F61-6. PubMed ID: 8970679
[TBL] [Abstract][Full Text] [Related]
17. Model for intracellular Lamivudine metabolism in peripheral blood mononuclear cells ex vivo and in human immunodeficiency virus type 1-infected adolescents.
Zhou Z; Rodman JH; Flynn PM; Robbins BL; Wilcox CK; D'Argenio DZ
Antimicrob Agents Chemother; 2006 Aug; 50(8):2686-94. PubMed ID: 16870759
[TBL] [Abstract][Full Text] [Related]
18. Intracellular zidovudine (ZDV) and ZDV phosphates as measured by a validated combined high-pressure liquid chromatography-radioimmunoassay procedure.
Slusher JT; Kuwahara SK; Hamzeh FM; Lewis LD; Kornhauser DM; Lietman PS
Antimicrob Agents Chemother; 1992 Nov; 36(11):2473-7. PubMed ID: 1489190
[TBL] [Abstract][Full Text] [Related]
19. An open randomized controlled trial of zidovudine plus lamivudine versus stavudine plus lamivudine.
Foudraine NA; de Jong JJ; Jan Weverling G; van Benthem BH; Maas J; Keet IP; Jurriaans S; Roos MT; Vandermeulen K; de Wolf F; Lange JM
AIDS; 1998 Aug; 12(12):1513-9. PubMed ID: 9727573
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous measurement of intracellular triphosphate metabolites of zidovudine, lamivudine and abacavir (carbovir) in human peripheral blood mononuclear cells by combined anion exchange solid phase extraction and LC-MS/MS.
Robbins BL; Poston PA; Neal EF; Slaughter C; Rodman JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):310-7. PubMed ID: 17197254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
